AbbVie (NYSE:ABBV) is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. AbbVie employs approximately 30,000 people worldwide and markets medicines in more than 170 countries.
We focus on ground-breaking medicines to address chronic progressive diseases, the most widespread and debilitating diseases, chronic disabling neurological conditions and impairments, including in rheumatology, dermatology, oncology, Parkinson’s disease and Alzheimer’s, HIV, hepatitis C, cystic fibrosis, endometriosis, uterine fibroids and diabetic nephopathy.
are scientists, researchers, communicators, manufacturing specialists,
regulatory experts, marketing professionals and more. We’re also parents,
brothers, sisters, friends, community leaders and volunteers. We come together
every day to create, discover and deliver new ways to improve people’s health.